The Arterial Revascularization Trial (ART) is a randomized comparison of bilateral internal mammary artery (BIMA) versus single internal mammary artery (SIMA) grafting in coronary artery bypass graft (CABG) surgery and is one of the largest randomized trials of surgery ever conducted. ART is also one of the largest studies of contemporary CABG with a high proportion of off-pump surgeries (41%). The objective of this post hoc analysis was to evaluate the surgical process and 1-year outcomes for surgery performed on-pump compared with off-pump.
INTRODUCTION
The recently reported Taxus Drug Eluting Stent versus coronary artery bypass surgery for the treatment of narrowed arteries (SYNTAX) trial confirms that coronary artery bypass grafting (CABG) continues to offer a significant survival advantage as well as a marked reduction in subsequent myocardial infarction (MI) and the need for repeat revascularization, in comparison with stenting, in most patients with left main or three-vessel coronary artery disease (CAD) who require intervention in addition to optimal medical therapy [1] . The Freedom Trial has reported similar findings in patients with diabetes [2] .
The Arterial Revascularization Trial (ART) is a randomized trial of 3102 patients with multivessel CAD who received single internal mammary artery (SIMA) or bilateral internal mammary artery (BIMA) grafts in addition to other supplemental grafts to determine if BIMA grafting has an additional survival advantage at 10 years. Surgery was performed by 167 surgeons in 28 centres in 7 countries and the 1-year outcome, in terms of mortality, MI, stroke (CVA) and the need for repeat revascularization, was reported in 2010 [3] . There were no significant differences in any of these end-points between SIMA and BIMA, but an increase in sternal wound reconstruction in the BIMA group (1.9 vs 0.6%).
The ART protocol [4] did not specifically recommend whether surgery should be performed on-or off-pump: this was left entirely to the discretion of the individual surgeon. For a contemporary series of CABG, a high proportion of patients (41%) were performed off-pump. In the current study, we describe the outcome of on-pump and off-pump surgeries in this cohort of patients according to whether they had SIMA or BIMA grafts and, where appropriate, make comparisons with the findings of the recently published coronary artery bypass surgery (CABG) off or on pump revascularisation study (CORONARY) trial of 4752 patients randomized to on-pump or off-pump surgery [5, 6] .
METHODS
The protocol for ART has been published [4] . Briefly, ART is a twoarm randomized multicentre trial with patients being randomized equally to SIMA or BIMA grafts. All patients who met the inclusion criteria were potentially eligible for the study. Eligible patients were those with multivessel CAD (including urgent patients but not involving recent MI) undergoing CABG, and patients requiring single grafts or redo CABG were excluded. While the ART trial actively excluded patients with an evolving MI, it did include Non ST elevation myocardial infarction acute coronary syndromes. As ART was conducted in 28 hospitals in 7 countries, there was no formal definition of 'urgent', but it was accepted to include patients with acute coronary syndromes or those with very high risk anatomy for further events that mandated surgery on the same hospital admission.
Appropriate ethical permission was obtained for the trial and all patients provided their written informed consent. The study was sponsored by the University of Oxford and the trial was co-ordinated by the Clinical Trials and Evaluation Unit (CTEU) at the Royal Brompton and Harefield National Health Service Foundation Trust in London.
The randomization sequence was generated with randomly varying block sizes and stratified by centre to provide equal numbers in each group. Patients were enrolled and randomized by telephone call to the co-ordinating centre. To reduce the possibility of outcome events occurring between randomization and revascularization, it was recommended that surgery be performed within 6 weeks of randomization.
The primary outcome of ART is the comparison of all-cause mortality at 10 years of follow-up between patients randomized to SIMA or BIMA. Other main outcomes are all-cause mortality, MI, stroke, repeat revascularization, quality of life and cost-effectiveness. Serious adverse events were reported by the investigators in specific forms and two members of the Clinical Event Review Committee adjudicated each event (death, MI, stroke and repeat intervention). When the two adjudicators did not agree, the event was then judged by a third adjudicator. All other adverse events requiring or prolonging hospitalization were adjudicated by one member of the Committee. Sternal wound reconstruction was defined as any wound requiring further surgical intervention.
Statistical analysis
Demographic factors, clinical characteristics, and outcomes at 30 days and 1 year were summarized with counts ( percentages) for categorical variables, mean [standard deviation (SD)] for normally distributed continuous variables or median (range) for other continuous variables. We compared the on-pump and off-pump procedures for each baseline characteristic using a mixed-effect logistic regression model, fitting the group as the dependent variable and each baseline characteristic as the independent variable. We used an exchangeable covariance structure in the model to account for the clustering effect of surgeons. The analysis was stratified by allocated treatment group. Comparisons of the perioperative data between the two procedures were carried out using a generalized linear mixed-effect model. Similar adjustment for clustering of surgeons was included in the model. As a sensitivity analysis, a similar analysis was also carried out stratified by those who actually received SIMA and BIMA. Results from the sensitivity analysis were consistent with the results obtained from the main analysis. Since the pre-specified primary outcome is survival at 10 years, no formal comparisons were made for outcomes at 30 days or 1 year. All analyses were performed using Stata version 12.
RESULTS
In total, 3102 patients were enrolled into ART between 30 June 2004 and 20 December 2007 at 28 cardiac surgery centres in 7 countries. Screening logs completed at each centre showed that 28% of patients who met the eligibility criteria were actually randomized into the study. Of these, 1554 patients were randomized to SIMA and 1548 to BIMA, with the groups being well matched with respect to age, gender, ethnic origin, body mass index (BMI), systolic blood pressure and smoking status. The groups were also well matched for comorbidities including diabetes, previous stroke or transient ischaemic attacks (TIAs) and peripheral vascular disease. Both groups had similar severity of angina and breathlessness and a similar incidence of previous MI and/or percutaneous coronary intervention with stenting.
In total, 167 surgeons participated in the trial (excluding 134 cases for which it was not obvious who the primary surgeon was and 24 who did not have surgery). Of these, 74 surgeons (44%) performed at least 10 operations. Figure 1 shows graphically the proportion of patients who were treated off-pump by each of these 74 surgeons: 46% performed no off-pump surgery, 19% performed <20% as off-pump surgery, 8% performed 20-40% as off-pump surgery, 3% performed 40-60% as off-pump surgery, 4% performed 60-80% as off-pump surgery and 20% performed over 80% of operations as off-pump surgery. In summary, almost twothirds of surgeons performed <20% of cases as off-pump surgery, while approximately one-fourth performed over 60% of cases offpump. Only a minority of 11% had a truly mixed practice, performing 20-60% of cases off-pump.
Demographic characteristics
The preoperative demographic characteristics of both the SIMA (n = 1554) and the BIMA (n = 1548) groups, with respect to onpump and off-pump surgeries, are described in Table 1 . There were no statistically significant differences in the baseline variables between on-pump and off-pump within each treatment group except for smoking status, ethnic origin, New York Heart Association (NYHA) class and CCS class.
In the SIMA and BIMA groups 59 and 58% of patients were done on-pump, and 40 and 41% off-pump, respectively. Eighty-six percent of all patients were male with a mean age of 63.6 years. The mean BMI was identical in both the SIMA and BIMA groups whether the surgery was done on-or off-pump. A history of diabetes was present in 22-25% of patients across the four subgroups with the incidence rate of insulin-dependent diabetes being 5-6% and the incidence rate of non-insulin-dependent diabetes ranging from 16 to 19%. Prior stroke (cerebrovascular accident) was documented in 2.6-3.7% of the four subgroups and prior TIA in 3.1-4.0% of all subgroups. Peripheral arterial disease was documented in 7% of the four subgroups. The incidence rate of previous MI among the four subgroups varied from 39 to 45% and the incidence rate of previous stenting from 15 to 17% (no statistically significant differences).
Perioperative data
The proportion of patients receiving three or more grafts performed in the on-pump SIMA and BIMA groups were both 83%, while for the off-pump groups these were 79% (P = 0.002) and 80% (P < 0.0001), respectively. The median number of grafts was identical at three grafts for the total on-pump and off-pump groups. The overall mean duration of on-pump surgery was 3.5 h for the SIMA group and 3.9 h for the BIMA group, a difference of 0.4 h or 24 min. The overall duration of off-pump surgery was shorter by 24 min in the SIMA group (P < 0.0001) and by 30 min in the BIMA group (P < 0.0001). The mean overall duration of ventilation for on-pump surgery was 600 min in the SIMA group and 620 min in the BIMA group. The overall duration of ventilation with off-pump surgery was shorter by 120 min in the SIMA group (P < 0.0001) and 100 min in the BIMA group (P < 0.0001) ( Table 2) .
The proportion of patients who returned to the theatre, predominantly for bleeding, varied from 3.1 to 4.5% across the groups and was not statistically different (P = 0.2 for SIMA and P = 0.7 for BIMA). The overall median blood loss for on-pump surgery for the SIMA and BIMA groups was, respectively, 500 and 510 ml. With off-pump surgery the median blood loss was lower by 150 ml in the SIMA group (P = 0.1) and 160 ml for the BIMA group (P = 0.09). For patients operated on-pump with SIMA or BIMA grafts the incidence rate of platelet use was, respectively, 3.1 and 4.2%. There was reduced use of platelets in off-pump surgery in both the SIMA and BIMA groups, though the differences were not significant.
The rate of balloon pump use was similar across the groups at 3.7-5.5%. There was no statistically significant difference in the need for renal support across the groups, varying from 4.0 to 6.4%. Table 3 examines clinical outcomes at 30 days and at 1 year regarding all-cause mortality, stroke (CVA), MI and repeat revascularization.
Clinical outcomes
The all-cause mortality rate at 30 days was 1.2% for both the SIMA and BIMA groups and the mortality rate at 1 year was 2.3 vs 2.5%, respectively. When analysed by on-pump and off-pump surgery, the mortality rate was 1.1 and 1.3% at 30 days and 2.3 and 2.4% at 1 year, respectively.
The overall incidence rate of stroke at 30 days was 1.1% (0.9-1.8% among the four subgroups) and at 1 year 1.7% (1.3-2.6% among the four subgroups), with no significant differences across the subgroups. 
ADULT CARDIAC
The overall incidence rate of MI at 30 days was 1.4% (0.6-1.9% among the four subgroups) and at 1 year 1.9% (1.1-2.5% among the four subgroups), with no significant differences across the subgroups.
The overall incidence rate of repeat revascularization was <0.5% at 30 days (0.1-0.9% among the four subgroups) and 1.5% at 1 year (1.1-2.4% among the four subgroups), with no clinically significant differences across the sub-groups.
The overall incidence rate of wound reconstruction was 1.2% at 30 days, 0.6% for the total SIMA group and 1.9% for the BIMA group. With SIMA the incidence rate of wound reconstruction was almost identical regardless of on-or off-pump surgery (0.5 vs 0.6%), but for the BIMA group the incidence rate of wound reconstruction was 2.2% for the on-pump group and 1.4% for the offpump group. Of the 9 patients in the SIMA group who required sternal wound reconstruction, 5 patients had a history of insulindependent or non-insulin-dependent diabetes. Of the 29 patients in the BIMA group who required sternal wound reconstruction, 14 had insulin-dependent or non-insulin-dependent diabetes.
DISCUSSION
The ART is one of the largest randomized trials of surgery, and especially cardiac surgery, ever conducted. The 1-year interim analysis of ART showed an overall very low mortality and major morbidity of contemporary CABG irrespective of whether the procedure was SIMA or BIMA, with a 30-day mortality rate of 1% and a 1-year mortality rate of 2.5% [3] . The second key finding was a higher incidence of sternal wound reconstruction observed in BIMA than SIMA (1.9 vs 0.6%). Although ART is primarily a randomized comparison of BIMA versus SIMA, it is also one of the largest studies of contemporary CABG with such a high proportion of off-pump surgery (41%), being 40% of the SIMA group and 42% of the BIMA group. In the SYNTAX trial, for example, only 14% of patients with three-vessel disease underwent off-pump CABG [1] . It must be emphasized, however, that as the patients were not randomized to on-pump or off-pump surgery, the current study is largely descriptive. Furthermore, from a statistical point of view it is not valid to describe differences simply by on-pump and off-pump surgery: they are also reported here by randomization to SIMA or BIMA, resulting in four subgroups.
Despite the variation in the proportion of off-pump surgery by individual surgeons and the lack of randomization to on-or offpump surgery, it is striking that the four subgroups appeared very ADULT CARDIAC well matched according to age, gender, diabetes (both insulindependent and non-insulin-dependent), a history of prior stroke, TIA, peripheral arterial disease, previous MI or previous stenting. In contrast, the apparently statistically significant differences in the four subgroups of patients with regard to smoking status, ethnic origin, NYHA and CCS classes were no longer significant after adjusting for the effect of clustering by individual surgeons. The mortality at 30 days (1.2%) and at 1 year (2.3%) was similar across the four subgroups. This compares favourably with the CORONARY trial in which the respective 30-day and 1-year mortality rates were 2.5 and 5% among 4752 patients randomized to onpump or off-pump surgery. For the other major clinical outcomes of stroke and MI, we found no difference between on-pump and offpump surgery, similar to the findings reported in CORONARY [5, 6] ,
In this study, the use of a second internal mammary artery (IMA) graft added 24 min to the length of surgery, while its overall duration was shorter by 26 min (24 min in the SIMA group and 30 min in the BIMA group) with off-pump surgery. Similarly, the overall median duration of ventilation was shorter in patients receiving off-pump surgery: 480 compared with 600 min in the on-pump SIMA group, and 520 compared with 620 min in the BIMA group.
The median blood transfusion for SIMA and BIMA grafts on-pump was very similar (500 vs 510 ml) as was the median blood transfusion for SIMA and BIMA off-pump (both 350 ml). In other words, off-pump surgery reduced the median blood loss by 150 ml in both groups. Similarly, the need for platelet transfusions was lower with off-pump surgery in both the SIMA and BIMA groups. There was no difference across the groups with regard to the need for balloon pumps or renal support.
One of the major conventional criticisms of off-pump surgery is that it leads to a reduction in the number of grafts performed. In the CORONARY trial, this was statistically, if not clinically, significant (3.0 vs 3.2; P < 0.001). However, in our study, the median number of grafts was identical at three grafts for the total on-pump and off-pump groups and across each of the subgroups. This is consistent with off-pump surgeons in ART being highly experienced in the technique.
In the design of ART, it was clearly envisaged that patients undergoing randomization would require at least two grafts and one of the exclusion criteria was any patient in whom a single graft was planned. However, for 19 patients (0.6% of the total population) it was found that it was not technically possible to use more than one IMA graft at surgery (in 10 cases because the obtuse marginal was deemed too small or could not be found, in 3 cases because of other unexpected intraoperative findings, in 1 case because the mammary artery was damaged and in 5 cases no clear explanation was recorded). However, this very small number of patients with a single graft is unlikely to influence the overall results of ART.
Off-pump surgery is frequently stated to reduce the incidence of stroke because of avoidance of the need for aortic cannulation. In the CORONARY trial [5, 6] , the incidence rate of stroke was 1.1 and 1.0%, respectively, for the on-pump and off-pump groups. In our study, the overall incidence of stroke was very similar for the SIMA and BIMA groups for surgery done on-pump and off-pump at 30 days (1.0 and 1.3%) and at 1 year (1.4 and 2.1%). It is possible that off-pump surgery only achieves its full potential to reduce the risk of stroke if, in addition to the absence of aortic cannulation, there is no aortic manipulation at all by avoiding any aortic crossclamping or side biting (i.e. a true no-touch aortic technique [7] ).
The overall incidence rate of repeat revascularization was 0.5% at 30 days (0.3% for the total on-pump group and 0.8% for the total off-pump group). This is almost identical to the findings in the CORONARY trial where repeat revascularization was 0.2% for the on-pump group and 0.7% for the off-pump group. Almost two-thirds of repeat revascularizations at 30 days in our trial were for graft failure with the remainder due to new disease in the coronary arteries.
By 1 year in ART, repeat revascularization had been performed in 1.5% of all patients (1.3% for the total on-pump group and 1.7% for the total off-pump group), again very similar to the findings in CORONARY (respectively, 0.8 vs 1.4%). The precise reason for repeat revascularization is currently being investigated but offpump surgery is usually associated with higher rates of repeat revascularization, through both a lower number and quality of grafts [8] . The relatively low number of repeat revascularizations in our trial and especially for off-pump surgery is, however, consistent with highly experienced surgeons performing the off-pump surgery as was also the case for CORONARY. In contrast, in the randomised on/off bypass trial, where off-pump surgeons were less experienced, the respective repeat revascularization rates at 1 year were 4.6 and 3.4% [8] .
As previously reported, the overall incidence rate of wound reconstruction was 1.2% at 30 days, being 0.6% for the total SIMA group and 1.9% for the total BIMA group (P < 0.05). At 30 days, the total incidence rate of wound reconstruction was 1.4% for the on-pump group and 1% for the off-pump group. However, whereas the incidence was very similar for both on-pump and off pump surgery within the SIMA group (0.5 vs 0.6%), the incidence rate of wound reconstruction was 2.2% for the on-pump BIMA group and 1.4% for the off-pump BIMA group. Diabetes is a particularly well-recognized risk factor for impaired sternal wound healing and it is therefore noteworthy that while the incidence of diabetes was 25% in all subgroups, the incidence rate was 50% in patients requiring wound reconstruction. It is highly likely that the incidence of sternal wound reconstruction could be reduced in the BIMA group by judicious patient selection (e.g. avoiding BIMA use in either obese diabetic patients or those with respiratory impairment) as well as modification of the IMA harvesting technique (i.e. using a skeletonized rather than pedicled technique to preserve collaterals and sternal blood supply).
There was a wide variation in the proportion of cases performed off-pump by participating surgeons in ART and, as can be seen in Fig. 1 , two centres, in particular, contributed large numbers of off-pump patients. It is not clear if the surgeons performing relatively low volumes of off-pump surgery reserved this technique for higher risk cases. For example, it is possible that some surgeons used off-pump surgery preferentially in patients with calcified aortas, peripheral vascular disease and impaired respiratory or renal function. If this was also the situation in patients with diseased aortas, where the surgeon preferred to use offpump surgery, but not a no-touch aortic technique, then this could have resulted, in the absence of randomization, in artificially higher incidence of neurological injury in the 'off-pump' group.
We did not carry out a formal analysis to assess the relationship between the outcomes and the volume of off-pump surgery that individual surgeons performed because this is likely to be confounded with the total number of operations that each surgeon performed. However, the relationship between volume and surgical outcomes for on-pump and off-pump surgery is very well documented in the literature [9] and recently a systematic review has suggested that the same relationship exists for off-pump surgery in larger cohorts of patients [10] .
Overall, the results of the current analyses demonstrate that surgeons familiar with both on-pump and off-pump techniques, whether using SIMA or BIMA grafts, can produce excellent results. Furthermore, our results are also entirely consistent with the recent largest randomized trial of on-pump and off-pump surgery, the CORONARY trial [5, 6] , in which there were no significant differences in any clinical end-point between on-pump and off-pump surgery.
Study limitations
The technique of performing CABG was at the discretion of the operating surgeon. Consequently, although there is some reassurance that baseline characteristics were similar among the subgroups, it must be emphasized that the patients were not randomized to on-pump or off-pump surgery and, consequently, the trial was not powered to compare outcomes on this basis. Thus, the analysis presented in this study is wholly descriptive. It should also be noted that there was considerable variation in the proportion of off-pump CABG per individual participating surgeon and that two surgeons in particular contributed a large number of off-pump cases.
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